Stockscreener 앱 받기
1.44
5.26%
-0.08
전일 마감가:
$1.52
열려 있는:
$1.49
하루 거래량:
1.11M
Relative Volume:
1.37
시가총액:
$132.31M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-1.5824
EPS:
-0.91
순현금흐름:
$-31.63M
1주 성능:
-10.56%
1개월 성능:
+30.91%
6개월 성능:
+74.50%
1년 성능:
+47.18%
1일 변동 폭
$1.42
$1.52
1주일 범위
$1.42
$1.65
52주 변동 폭
$0.49
$2.00
Context Therapeutics Inc Stock (CNTX) Company Profile
명칭
Context Therapeutics Inc
전화
267-225-7416
주소
2001 MARKET STREET, PHILADELPHIA
CNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
1.44 | 139.66M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | Guggenheim | Buy |
| 2025-04-21 | 개시 | William Blair | Outperform |
| 2025-01-08 | 개시 | JMP Securities | Mkt Outperform |
| 2024-11-25 | 개시 | D. Boral Capital | Buy |
| 2024-05-16 | 개시 | Piper Sandler | Overweight |
Context Therapeutics Inc 주식(CNTX)의 최신 뉴스
Ideas Watch: How does Context Therapeutics Inc perform in inflationary periodsMarket Trend Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech Context Therapeutics grants 120,000 stock options to new hires - Stock Titan
CEO Moves: Can Context Therapeutics Inc. stock double in the next year2025 Market Sentiment & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Context Therapeutics Inc. (NASDAQ:CNTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Context Therapeutics Welcomes Andy Pasternak as New Chairman of the Board - MSN
Will Context Therapeutics Inc. stock benefit from automationPortfolio Gains Summary & Risk Adjusted Swing Trade Ideas - Улправда
Context Therapeutics Inc.Common Stock (NQ: CNTX - FinancialContent
User | inyoregister.comContext Therapeutics Inc.Common Stock (Nasdaq:CNTX) Stock Quote - FinancialContent
Pasadena Star News - FinancialContent
Can Context Therapeutics Inc. stock hit record highs againWeekly Earnings Recap & Weekly Top Stock Performers List - Улправда
Will Theranexus Société Anonyme (3VG) stock beat value stocks2025 Big Picture & Proven Capital Preservation Methods - ulpravda.ru
Why Context Therapeutics Inc. stock is trending among retail tradersJuly 2025 Rallies & Weekly Breakout Watchlists - Улправда
Why Context Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Sentiment & Daily Profit Maximizing Tips - Улправда
Dow Theory LettersContext Therapeutics Inc.Common Stock (Nasdaq:CNTX) Stock Quote - FinancialContent
Will Enliven Therapeutics Inc. stock see insider buyingWeekly Stock Report & AI Forecasted Stock Moves - ulpravda.ru
Context Therapeutics Highlights T Cell Engager Pipeline Strategy - TipRanks
Context Therapeutics Inc Updates Corporate Presentation on T Cell Engagers - TradingView — Track All Markets
Why Context Therapeutics Inc. stock remains on buy listsGrowth Stock Opportunities & Fast Profit Trading Tips - ulpravda.ru
ALNA pre-market +3.16% on 252,311,606 shares 06 Jan 2026: check catalysts - Meyka
After-Hours Biotech Rally: Alumis, Genelux, Bright Minds, Context Therapeutics Post Big Gains - Nasdaq
Wondering what's happening in today's after-hours session? - Chartmill
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 UpsideDVLT, UFG, VRME, ARBE More Inside - openPR.com
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 Upside – DVLT, UFG, VRME, ARBE More Inside - FinancialContent
Uni-Fuels Holdings Limited (UFG) Stock, Price, News, Quotes, Forecast and Insights - MSN
Akero Therapeutics, Inc. (AKRO) Stock Analysis: Potential 3.39% Upside In Biotech Innovation - DirectorsTalk Interviews
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
MACD Signals Flash Warning for CRP Risk Management Limited StockAnalyst Upgrades & High Yield Portfolio Growth - bollywoodhelpline.com
Raconteur Global Resources Limited Inches Toward Key Resistance — Will It BreakChart Pattern Recognition & Small Budget Wealth Building - bollywoodhelpline.com
BDH Industries Limited Building a Base Near SupportHead and Shoulders Patterns & High Profit Trading Alerts - bollywoodhelpline.com
MACD Signals Flash Warning for Sagar Diamonds Limited StockEarnings Beat Highlights & Free Stock Price Trend Analysis - bollywoodhelpline.com
Jones Trading Initiates Coverage of Context Therapeutics (CNTX) with Buy Recommendation - Nasdaq
Context Therapeutics (NASDAQ:CNTX) Coverage Initiated by Analysts at Jones Trading - MarketBeat
This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Aug Reactions: Why Context Therapeutics Inc. stock could benefit from AI revolutionPortfolio Gains Report & AI Powered Market Entry Strategies - moha.gov.vn
Published on: 2025-12-21 00:47:49 - Улправда
Is Context Therapeutics Inc. stock a buy before product launchesJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - Улправда
Bearish Setup: Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Levels & Weekly Stock Breakout Alerts - Улправда
Breakouts Watch: How Context Therapeutics Inc. stock compares to market leaders2025 Momentum Check & Community Verified Watchlist Alerts - Улправда
Context Therapeutics Earnings Notes - Trefis
Why Context Therapeutics Inc. stock is a must watch in 2025Trade Signal Summary & Weekly Stock Performance Updates - DonanımHaber
Context Therapeutics Inc. (NASDAQ:CNTX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
How Context Therapeutics Inc. stock compares to market leadersWeekly Gains Summary & Weekly Breakout Watchlists - Улправда
Can Forum Energy Technologies Inc. stock attract ESG capital inflowsWeekly Investment Summary & Technical Pattern Alert System - Улправда
Is ABR.PRD stock trading near support levelsWeekly Stock Analysis & Consistent Growth Stock Picks - Улправда
SJVN Limited (533206) Stock Experiences Sudden DipMoving Average Strategies & Free Tremendous Portfolio Expansion - Bollywood Helpline
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards - GlobeNewswire
Context Therapeutics (NASDAQ:CNTX) Shares Up 8.7%What's Next? - MarketBeat
Context Therapeutics (NASDAQ:CNTX) Shares Up 8.7% – What’s Next? - Defense World
Oncotelic Therapeutics Study Reveals Context-Dependent Biomarker Significance in Liver and Pancreatic Cancers - citybuzz -
Context Therapeutics Inc (CNTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Context Therapeutics Inc 주식 (CNTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
4.73%
0.92%
자본화:
|
볼륨(24시간):